| Pharmaceutical Information |
| Drug Name |
Cyproterone |
| Drug ID |
BADD_D00554 |
| Description |
An anti-androgen that, in the form of its acetate (cyproterone acetate), also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females. |
| Indications and Usage |
For the palliative treatment of patients with advanced prostatic carcinoma. |
| Marketing Status |
Not Available |
| ATC Code |
G03HA01 |
| DrugBank ID |
DB04839
|
| KEGG ID |
D07766
|
| MeSH ID |
D003534
|
| PubChem ID |
5284537
|
| TTD Drug ID |
D06AEO
|
| NDC Product Code |
53104-7635; 46439-8720; 59010-000 |
| Synonyms |
Cyproterone | Cyproterone, 1alpha,2 alpha,9 beta,10 alpha-Isomer |
|
| Chemical Information |
| Molecular Formula |
C22H27ClO3 |
| CAS Registry Number |
2098-66-0 |
| SMILES |
CC(=O)C1(CCC2C1(CCC3C2C=C(C4=CC(=O)C5CC5C34C)Cl)C)O |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
